Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-20-004351

Options or other derivatives

  • General Counsel/Secretary acquired 616,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Leavitt Chase C. · General Counsel/Secretary

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-03-17 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +616,700 616,700 D
Loading xslF345X03/ownership.xml…